Human Ig Kappa Light Chain Antibody MAB100501-100: R&D Systems
How is Active Multiple Myeloma Defined? - HealthTree for Myeloma
Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosis - Cytotherapy
Immunoglobulin-Related Amyloidosis: Practice Essentials, Pathophysiology, Etiology
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment - Gertz - 2020 - American Journal of Hematology - Wiley Online Library
Living With - HealthTree for Myeloma
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
The Heavy Chain Diseases: Clinical and Pathologic Features
sGT LCL clonality assessed based on kappa-lambda light chain exclusion.... | Download Scientific Diagram
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Kappa and Lambda Light Chains - HealthTree for Myeloma
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Multiple Myeloma: The Role of Free Light Chains
Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients | Bone Marrow Transplantation
Light-chain amyloidosis: SCT, novel agents and beyond | Bone Marrow Transplantation
